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Background: Patients on antiretroviral therapy have higher risk of developing adverse drug reactions (ADRs). The
impact of ADRs on treatment adherence, treatment outcomes and future treatment options is quiet considerable.
Thus, the purpose of this study was to describe the common self-reported ADRs and their impact on antiretroviral
treatment.
Methods: Cross-sectional study was conducted at antiretroviral therapy (ART) clinic of Gondar University Hospital.
Semi-structured interview questionnaire was used to extract self-reported ADRs, socio-demographic, and psycho-social
variables. Variables related to antiretroviral medication, laboratory values and treatment changes were obtained from
medical charts. Chi-square and odds ratio with 95% confidence interval were used to determine the associations of
dependent variables.
Result: A total of 384 participants were enrolled. At least one adverse drug reaction was reported by 345 (89.8%) study
participants and the mean number of ADRs reported was 3.7 (±0.2). The most frequently reported ADRs were nausea
(56.5%) and headache (54.9%). About 114 (31.0%) participants considered antiretroviral therapy to be unsuccessful if
ADRs occurred and only 10 (2.6%) decided to skip doses as ADRs were encountered. Based on chart review, treatment
was changed for 78 (20.3%) patients and from which 79% were due to documented ADRs (p = 0.00). Among them, CNS
symptoms (27.4%) and anemia (16.1%) were responsible for the majority of changes. Around four percent of patients
were non-adherent to ART. Non-adhered participants and those on treatment changes were not statistically associated
with self-reported ADRs. Only unemployment status (AOR = 1.76 (1.15 - 2.70), p = 0.01) and ADR duration of less than
one month (AOR = 1.95 (1.28-2.98), p = 0.001) were significantly associated with self-reported adverse effects of three or
more in the multivariate analysis.
Conclusion: Self-reported ADRs to antiretroviral therapy are quite common. More of the reactions were of short
lasting and their impact on adherence and treatment change were less likely. However, documented ADRs were the
most prevalent reasons for ART switch. Moreover, the level of unemployment was a strong predictor of self-reported
ADRs.
Keywords: Perceived adverse effect, Antiretroviral therapy, Self-report ADRs* Correspondence: mail2wondm@gmail.com
1Department of Pharmacology, School of Medicine, Addis Ababa Science &
Technology University, Addis Ababa, Ethiopia
Full list of author information is available at the end of the article
© 2014 Tadesse et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
Tadesse et al. BMC Pharmacology and Toxicology 2014, 15:32 Page 2 of 9
http://www.biomedcentral.com/2050-6511/15/32Background
Worldwide, 34 million people are living with HIV from
which 22.9 million (67.4%) are in the Sub-Saharan African
countries. In 2010, there were an estimated 2.7 million
new HIV infections and 1.8 million deaths due to AIDS
[1]. According to literatures, the overall prevalence of
HIV/AIDS in Ethiopia is 2.1% in 2010 [2]. The use of ef-
fective antiretroviral therapy (ART) has dramatically im-
proved the pattern of morbidity and mortality among HIV
infected patients, changing the disease pattern to a chronic
manageable infection [3,4]. Highly active antiretroviral
therapy (HAART) is known to increase CD4+ lymphocyte
cell count which enhances immune system in HIV pa-
tients. The clinical benefits of HAART is characterized by
increased survival and longevity in HIV patients [5]. How-
ever, these clinical benefits are associated with aversive ad-
verse drug reactions (ADRs). Edward and his colleague
defined ADR as an appreciably harmful or unpleasant re-
action resulting from an intervention related to the use of
a medicinal product, which predicts hazard from future
administration and warrants prevention or specific treat-
ment, or alteration of the dosage regimen, or withdrawal
of the product [6].
Antiretrovirals, like most chronically administered
drugs, are reported to have adverse reaction and particu-
larly higher occurrences are seen at the beginning of ART
[4,7,8]. Moreover, long term adverse effects such as
lipodystrophy and neuromotor disorders may be en-
countered in latter stages of treatment [4]. Not only this,
studies also showed that ADRs could be a source for new
co-morbidities and hospital admission [9,10]. ADRs due
to antiretrovirals can range from mild gastrointestinal
disturbance [11] to serious adverse effects including
hematological disorders [10], hepatotoxicity [12,13] and
lactic acidosis [12]. A study done in Brazil among pa-
tients initiating ART in the first six month of therapy
showed that at least one adverse reaction was reported
by 92.2% of the participants while 56.2% reported four or
more different reactions [8]. Singh et al. reported that
86% of patients had at least one ADR, of which, the most
common observed was peripheral neuropathy [14]. A
prospective observational study by Nagpal et al. reported
that about 90% of patients experienced ADR [11]. In this
study, non-compliance due to ADRs was observed in
28.9% of patients. Clinical benefits from ART can only be
achieved with strict adherence and life-long treatment
[3,4]. However, ADRs are considered the most limiting
factor that compromises patient compliance and adher-
ence. A number of authors reported ADRs as reasons for
non-adherence [4,11,15-17]. Moreover, meta-analysis and
review studies reported that non-adherence to treatment
is one of the factors that leads to treatment failure and
poor prognosis [12,18]. ADRs leave fewer options to cli-
nicians and practitioners and compromise antiretroviraldrug efficacy particularly if the intention is to withdraw
and substitute the offending agent for the other. Fur-
thermore, substitution is difficult in resource limited
settings. Overall, ADRs become a concern and public
health problem particularly in developing nations as ad-
equate drug toxicity monitoring and reporting schemes
barely existed. Lack of ADR monitoring and reporting
system underestimates the burden of ART associated
ADRs. Therefore, utilizing self-reported ADR studies
could be one way of addressing such gaps. The aim of this
study was thus, to assess the most common self-reported
ADRs, determine associated factors and assess impacts of
ADRs on treatment at ART clinic of Gondar University
Hospital (GUH).
Methods
Cross–sectional study was conducted at Gondar University
Hospital (GUH) which is located in Gondar town of
the Amhara regional state, 738 km North-west of Addis
Ababa. GUH is the first teaching and referral hospital
for the region. The hospital opened the area’s first ART
clinic and began offering ART services in March 2002.
At the time of the study period, GUH ART clinic was
providing ART service to 6,163 HIV/AIDS patients.
The study was carried out in ART clinic of GUH over
three months period from April 1 to June 30, 2012.
The study population was comprised of 4600 adult pa-
tients (18 years and above) who were active and on fol-
low up at the ART clinic. Briefly, recruitment criteria
were documented HIV positive status, at least 18 years
of age, only those who had started only ART. Patients
who were taking other medications along with ART, short-
course ART for the sole purposes of prevention of mother-
to-child transmission and post-exposure prophylaxis were
excluded from the study.
Patients receiving ART treatment at GUH ART clinic
were the sampling population for the study. The sample
size was calculated based on a single proportion formula.
The following parameters were used to calculate the
sample size: total population of adult patients on ART
4600, proportion of patients who report at least one ad-
verse reaction to ARTs 50% and 95% confidence interval
with a marginal error of 5%. Additional 10% allowance
for refusal to participate in the study was considered,
which resulted in a total sample of 384. Using systematic
random sampling method, patients were selected from
the waiting room of ART clinic, on the day of their visit
to refill ART medications. For data collection, a semi-
structured interview questionnaire was used (Additional
file 1). The questionnaire was first prepared in English,
and then translated into Amharic. The questionnaire con-
sisted of a list of common ART related symptoms, which
were identified based on previously published studies
[17,18] and pretested questionnaire. Before interviewing,
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verse drug reactions to ARTs. They were also asked if they
had received any counseling about ADRs previously from
physicians, pharmacists and nurses. In this study, adverse
drug reaction refers to any undesirable symptoms reported
by patients which they perceived it as a result of ART use.
Respondents were asked whether they had experienced
any of the range of options from the list. Additionally, pa-
tients were asked to report any other ADRs encountered
during the course of therapy. In such a way, the outcome
of interest was the number of adverse drug reactions which
had occurred at least once since they had initiated ART.
Besides, socio-demographic, general health condition of
the patient, questions related to impacts of self-reported
ADRs on the treatment, social and psychological compo-
nents were included. Patient medication chart review
was also employed to extract information related to
ART medications, ART treatment change, reasons for
treatment change (documented ADRs, treatment failure,
co-morbidity), baseline and current laboratory values. Re-
cent self-reported antiretroviral medication adherence was
assessed based on patients’ report on missed doses of ART
medications over the past three-days.
The textual data obtained were sifted, organized and
coded; and then entered and analyzed using SPSS statis-
tical software version 20. Descriptive analysis of partici-
pants and self-reported adverse drug reactions were
carried out. Logistic regression was employed for bivari-
ate and multivariate analysis. Variables with a p value of
less than 0.2 were fitted to the final model. Median
number of self-reported ADRs was considered as the
cutoff point. Patients who reported three or more types
of reactions were compared to those who reported fewer.
The strength of associations between self-reported adverse
drug reactions and selected variables was estimated by the
odds ratio with a 95% confidence interval. Chi-square test
was also carried out to measure the association of selected
self-reported ADRs with those factors affecting ART treat-
ment. Statistical associations were considered significant
at p < 0.05.
The following operational definitions were used:
 Non-adherence – failed to take >95% or missing
dose of the antiretroviral drugs prescribed in the last
three days prior to the interview
 Healthy – asymptomatic, physical activity not affected
and not confined to bed at the start of treatment
 Mild illness – mild symptoms, physical activity not
affected and not confined to bed at the start of
treatment
 Severe illness – recurrent illness with wide range of
infections, frequent confinement to bed, marked
physical activity limitation and/or hospitalized due
to prevailing conditions.Ethical consideration
The study was approved by the ethical review committee
of School of Pharmacy, College of Medicine and Health
Sciences, University of Gondar. Written informed consent
was obtained from the respondents for the interview. Be-
sides, confidentiality of the information was strictly main-
tained during data collection and data analysis process.
Each interview questionnaire was assigned a study identifi-
cation number. Respondents were also informed that their
information would be used anonymously.
Result
A total of 384 participants were enrolled in the study.
Descriptive socio-demographic variables indicated that
85.1% of the participants were below 40 years old, 66.9%
were females, 55.2% were married and 38.8% were un-
employed. Most study participants had some education,
primary and above (74.7%) and 90.1% were from urban
dwellings. With regard to clinical status, mean level of
CD4 cells/mm at the initiation of ART was 165.68 ± 93.8
while at the time of data collection was 376.7 ± 181.3.
The majority of participants (52.9%) CD4 level was over
350. Participants had received ART for a mean of 42.3
(±24.1) months of treatment duration and had most re-
cently been on ART triple regimen consisted of AZT/
3TC/NVP (40.1%). Overall, only 3.6% of the participants
taking ART medications indicated that they had skipped
pills in the prior three days to result in less than 95% ad-
herence. Initially, most patients were mild to severely ill.
However, after the start of ART medication, most re-
spondents’ health status was improved in terms of body
weight and CD4 level. In the contrary, social interaction
of most participants was not changed (Table 1).
Based on the chart review, one out of five participants
had changed their first ART because of ADRs (79%),
treatment failure (13%), tuberculosis co-morbidity (5%)
and pregnancy (3%). There were statistically significant as-
sociation with these documented ADRs (p = 0.00). Central
nervous system symptoms, anemia and peripheral neur-
opathy were among the major documented ADRs respon-
sible for treatment change (Table 2).
At least one ADR was reported by 345 (89.8%) patients
due to the use of ART and the mean number of ADRs
reported was 3.7 (±0.2). Most patients (94.6%) stated
that they had received counseling regarding adverse
reaction to ART from physicians, pharmacists or nurses
before initiating and in the course of ART therapy.
The most common self-reported adverse drug reactions
were nausea (56.5%), headache (54.9%) and fever (40.9%)
(Table 3).
Table 4 present results of the logistic regression ana-
lysis. In the bivariate analysis, unemployed status, urban
residents, ART duration of more than four years, non-
adhered patients and ADR duration of less than one
Table 1 Descriptive analysis of socio-demographic, clinical
variables and health status of the participants, ART clinic,
Gondar University Hospital, June 2012
Variables n(%), N = 384
Socio-demographic
Education ( primary and above) 287(74.7)
Work status (unemployed) 149 (38.8)
Age (≤40 years) 327(85.2)
Gender (female) 257(66.9)
Marital status ( married) 212 (55.2)
Residency (urban) 346 (90.1)
Clinical variables
Duration of ART ( ≤4 years) 155(40.4)














General health at the start of treatment
Healthy 50(13.0)
Mild to severely ill 334 (87.0)















Table 2 Distribution of major reasons and documented
ADRs responsible for treatment change (based on chart
review), ART clinic, Gondar University Hospital, June 2012
Variables n (%)*
Reasons for treatment change (N = 78)
Due to ADRs 62 (79.0)**
Due to treatment failure 10 (13.0)
Due to TB co-morbidity 4 (5.0)
Due to pregnancy 2 (3.0)
Documented ADRs responsible for treatment change (N = 62)
CNS symptoms 17 (27.4)
Anemia 10 (16.1)
Peripheral neuropathy 9(14.5)
Skin rash 8 (12.9)
Lipodystrophy 7(11.3)
Weight loss 4(6.5)
Stomach ache 3 (4.8)
Hepatotoxicity 3 (4.8)
Dental illness 1 (1.6)
*Percent frequency out of the total number of patients (reasons for treatment
change, N = 78; ADRs responsible for treatment change, N = 62). The most
frequent reasons are highlighted in bold type.
**95% CI, 0.68-0.88; p =0.00.
Table 3 Most common self-reported adverse drug reactions
of antiretroviral therapy, ART clinic, Gondar University
Hospital, June 2012






Loss of appetite 130 (34)
Insomnia 102 (26.6)
Depression/stress 99 (25.8)
Skin rash 85 (22.1)
Night mare 72 (18.8)
Diarrhea 41 (10.7)
Oral ulceration/dry mouth 35 (9.1)
Anxiety 23 (6.3)
Others** 10 (2.6)
*number of frequency and percent proportions, total number of
participants (N = 384).
**includes tingling in hands or feet, anemia.
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Table 4 Logistic regression analysis of selected variables and adverse drug reactions to ART, ART clinic, Gondar
University Hospital, June 2012
Variables Total (N)* Self-reported ADRs** (≥3), n = 229 OR (95% CI)*** P value AOR( 95% CI)†
Age
≤ 40 years 327 192(58.7) 1
>40 years 57 37(64.9) 1.28(0.69, 2.38) 0.44
Gender
Female 257 152(59.1) 1
Male 127 77(60.6) 1.06 (0.69, 1.64) 0.78
Education
Illiterate 97 58(59.8) 1
≥primary 287 171(59.6) 0.92 (0.58, 1.46) 0.72
Work status
Employed 149 78(52.3) 1 1
Non-employed 235 151(64.2) 1.82 (1.17, 2.84) <0.01 1.76 (1.15, 2.70)a
Marital status
Married 212 121(57.1) 1
Non- married 172 108(62.8) 1.16 (0.75, 1.82) 0.50
Residency
Urban 346 211(61.0) 1
Rural 38 18(43.4) 0.58(0.28, 1.18) 0. 14
Duration of ART
≤4 years 155 85(54.8) 1
>4 years 229 144(62.9) 1.39 (0.92, 2.21) 0.11
ART treatment change
Yes 78 42(53.8) 1
No 306 187(61.1) 1.35(0.82,2.22) 0.24
Current CD4 level
≤350 181 107(59.1) 0.96(0.64, 1.44) 0.85
>350 203 122(60.1) 1
Current ART regimen
AZT backbone 204 122(59.8) 1.01(0.67, 1.53) 0.94
Non-AZT backbone 180 107(59.4) 1
Adherence
Yes 370 223(60.3) 1
No 14 6(42.8) 0.50(0.17, 1.45) 0.2
ADR duration (self-reported)
≤1 month 212 140(66.0) 1.81(1.20, 2.74) 1.95(1.28,2.98)b
>1 month 172 89(51.7) 1 <0.01 1
*Percent frequency that refers to the total number of patients (N = 384). **Number and proportion of patients’ self-reporting 3 or more adverse drug reactions.
***Values represent odds ratio (OR) at 95% confidence interval. †Values represent adjusted odds ratio (AOR) at 95% confidence interval, ap = 0.01, bp = 0.001.
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different types of ADRs ( p < 0.2). Among the vari-
ables assessed for further analysis, unemployment status
(AOR = 1.76(1.15-2.70), p = 0.01) and ADR duration of
less than one month (AOR = 1.95 (1.28-2.98), p = 0.001)were significantly associated with self-reported adverse
effects of three or more in the multivariate analysis.
Results of the impacts of self-reported ADRs showed
that only 10 (2.6%) patients decided to skip doses as
ADRs were encountered. But, none of the self-reported
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ping trend. As a measure of impact of ADRs on patients’
perception regarding treatment, 114 (31.0%) of partici-
pants reported that they considered antiretroviral ther-
apy to be unsuccessful due to the ADRs that they
encountered. Moreover, it was found that such impacts
of reported ADRs showed significant association with
self-reported ADRs such as fever, vomiting, loss of appe-
tite, diarrhea, insomnia, lethargy, dry mouth and depres-
sion. Similarly, various types of reported ADRs were
significantly associated with the responses for questions
linked with patients’ social interaction (Table 5).
Discussion
This study was aimed at describing the commonly per-
ceived ADRs, characterizing the impact on patients tak-
ing ART and associated factors with self-reported ADRs
at ART clinic of Gondar University Hospital. Our find-
ings indicated a high proportion of patients (89.8%) re-
ported at least one adverse drug reactions because of
antiretroviral therapy since they began ART. This find-
ing is closely consistent with works of other studies that
showed a high proportion of patients on ART reported
at least one ADR to be as high as 86%-94% of the pa-
tients [8,11,14,19]. Almost, all these studies used a simi-
lar study design. This finding is relatively higher than
the reports by Luma et al. [20] in Cameron and de
Padua et al. [4] in Brazil. Our study assessed adverse re-
actions which were merely of patient self-report and
thus, those symptoms perceived as adverse drug reac-
tions to ARTs might be confounded with symptoms due
to HIV. This is more evident as most patients reported
fever as one of their ADR which is more likely to HIV
and concurrent infections. In such occasions, this might
lead to an overestimation of this outcome. On the other
hand, this difference might be due to differences in the
study design and lack of standardized definition of ADR
among the different studies. Moreover, genetic and ethnic
susceptibilities to ADR to a particular drug might also
explain the difference.
In this study, the most common reported ADRs were
from gastrointestinal symptoms; among which nausea
was highly prevalent constituting more than half of all
ADRs. In agreement with previous studies, gastrointes-
tinal complaints were the reactions most commonly en-
countered [4,8,11]. In a Brazilian study of 406 patients,
the most frequently reported adverse drug reaction was
nausea where the occurrence was as high as 51.2% [8].
In the contrary, Singh et al. [14] and Luma et al. [20] re-
ported that about a fifth of patients on ART developed
peripheral neuropathy. Yet, a self-report by Melangu
[19] in Pretoria, South Africa showed that sexual problems
were the highest adverse effects reported. Few studies
try to look the association between socio-demographicvariables and adverse drug reactions, our study showed no
difference in reported ADRs between age and sex differ-
ences. This finding is consistent with Eluwa et al. [7]. In
this study, only unemployment status and ADR duration
of less than one month were independently associated
with self-reported ADRs of three or more. On top of the
adverse drug reactions to ARTs, the level of unemploy-
ment in our study is a cause for concern because it results
in a lot of psychosocial problems. Around one third of pa-
tients reported depression, stress and anxiety among the
reported ADRs. Findings showed that unemployment is
one of the causes of mental health problems [21,22]. We
deduced that more of the reactions were of short lasting
and their impact on adherence and treatment change were
less likely. However, patient chart review showed that
switching therapy was identified as major intervention
used for the management of adverse reactions to ART in
this population. Of those patients who had their ART regi-
men switched, 79% ascribed the change in regimen to the
occurrences of adverse reactions due to ART. This is
higher than the findings in 2007 in Brazil where ADR was
found to account for 56.1% of all switches [4]. Unlike self-
reported ADRs, the most documented reactions were
more serious events like CNS symptoms, anemia and per-
ipheral neuropathy. The patients’ perception of adverse re-
actions would potentially attribute to non-adherence to
medications. But this study showed no difference in re-
ported ADRs between the adhered and non-adhered
population. We observed that 3.6% of patients were non-
adherent to ART. This result is lower than that of the re-
port by Nagpal et al. who reported non-adherence in
28.9% of Indian patients due to ADRs to ART (11). Other
reports also showed non-adherence rate of 13%-21%
[15,16,23]. The differences can be attributed to variation
in the adherence assessment method.
Only 2.6% of subjects skipped medications because of
perceived ADRs. Different studies mentioned various
reasons for missing doses; forgetting, being away from
home and being busy were the most common [16,24].
The lower rate of missing doses indicates the strength of
patient education system and competent follow up by
the health practitioners. However, perceived medication
side effects and ADRs influenced patients’ perception on
ART. Patients who considered ART as unsuccessful were
significantly associated with the common ADRs including
fever, GIT side effects, insomnia, lethargy and depression.
Furthermore, these medication ADRs demonstrated sig-
nificant influence on patient’s social interaction behavior.
For instance, 32.9% of the study subjects perceive that
people would avoid them when ADRs encountered and
some 32.2% tend to reduce social interaction. On contrary
to these, most of the study groups (80.0%) would love to
share their feeling about the ADRs with their family mem-
bers. Specifically, the result indicated a significant family
Table 5 Impacts of self-reported ADRs on perception of treatment and social interaction, ART clinic, Gondar University Hospital, June 2012
Variables n (%) Association of variables with specific ADRs (chi-square or fisher test)





Impacts on patients perception on treatment patients who:
Decided to skip medication due to ADRs* 10 (2.6) 0.54 0.51 0.35 0.55 0.26 0.48 0.20 0.21 0.42 0.78 0.26
Consider ART unsuccessful due to ADRs** 114 (31.0) 1.43 0.10 7.42b 5.00a 29.53c 25.93 c 14.47 c 24.43c 1.43 13.63c 13.70c
Impacts of ADR on patients’ social interaction patients who:
Perceive that people avoid them due to observed ADRs** 21 (32.9) 5.68 a 0.76 11.97c 12.7c 28.13c 26.67 c 18.28 c 23.15c 3.19a 8.45b 14.94c
Tend to reduce/avoid social interaction because of ADRs** 119 (32.2) 2.11 0.26 9.87 c 7.96b 33.20 26.67c 20.88 c 3.40
c 1.87 8.45b 6.70 c
Perceive family members avoid them when ADRs occurred ** 57 (15.4) 0.99 3.35a 2.19 0.06 0.08 1.01 0.45 3.40a 0.03 0.99 6.70b
Talk to family members about ADRs as it appears** 296 (80.0) 14.32c 10.24c 5.92 b 7.73b 4.34a 2.84 0.61 2.21 0.31 0.01 0.62




















Tadesse et al. BMC Pharmacology and Toxicology 2014, 15:32 Page 8 of 9
http://www.biomedcentral.com/2050-6511/15/32interaction of patients when ADRs such as fever, head-
ache, nausea, vomiting and lethargy had occurred.
This study has a number of limitations. The ADRs are
self-report and there were no further investigation of
laboratory tests and other diagnostic tests for ruling
out for other possible causes which could lead to over-
representation of ADRs. On the other hand, it might
lead to under-estimation of ADRs which might have
been detected clinically. Besides, the reporting could be
influenced by the patient’s ability to memorize events
related to adherence assessment and the duration of time
ADRs lasted.
Conclusion
Our study showed that perceived adverse drug reac-
tions due to antiretroviral therapy are very frequent and
prevalent in the studied population. More of the reactions
were of short lasting and their impact on adherence and
treatment change were less likely. Although treatment
change and self-reported ADRs were failed to show statis-
tical significance, documented ADRs were the most fre-
quent reasons for ART switch. Unlike self-reported ADRs,
documented ADRs were serious events. Moreover, the
level of unemployment was a strong predictor of self-
reported ADRs. Self-reported ADRs have a number of im-
pacts on the patients’ perception to ART and drug taking
behavior. Specific self-reported ADRs showed their influ-
ences on the patients’ perception to antiretroviral therapy
and social interactions. Particularly, self-reported ADRs
forced the patients to consider the antiretroviral therapy
as if it was unsuccessful. In addition, self-reported ADRs
demonstrated their potential threat to the patients social
interaction as the patients considered people avoid them
due to ADRs. Therefore, clinicians, caregivers and the pa-
tient himself/herself should actively collaborate for the
better ART outcome because ADRs are a potential threat
to the effectiveness of ART. ADR reporting, monitoring
and management should further be strengthened to en-
hance better ART service. Patient education on ART asso-
ciated ADRs should be an integral part of HIV care so as
to facilitate reporting and management.
Additional file
Additional file 1: Annex 1. Study questioner used to collect variables
and self-reported adverse drug reactions at ART clinic, Gondar University
Hospital, April 2012.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Data were collected by WTT and WHT. WTT, ABM and YTT contributed in
statistical analysis. All authors were involved in manuscript write-up and
correction. The final version of the submitted manuscript was approved by
all authors.Acknowledgements
Our appreciation extends to Gondar Hospital ART clinic staffs and to the
study participants, supervisors and data collectors for their fullest
participation. We also extend our appreciation to Mrs. Grum Zewdu,
Department of Medicine and Health Sciences, Addis Ababa Science and
Technology University for her relentless effort and help in the statistical
analysis. A special word of thanks goes to Professor Peggy Soul Odegard,
University of Washington, Seattle, USA for the language and grammar
editing. Also, we thank Mr. Solomon Debebe, English department, Addis
Ababa Science and Technology University for language and grammar
editing.
Author details
1Department of Pharmacology, School of Medicine, Addis Ababa Science &
Technology University, Addis Ababa, Ethiopia. 2Department of Clinical
Pharmacy, School of Pharmacy, University of Gondar, Gondar, Ethiopia.
3Department of Internal Medicine, School of Medicine, University of Gondar,
Gondar, Ethiopia.
Received: 21 August 2013 Accepted: 20 June 2014
Published: 23 June 2014References
1. WHO, UNAIDS and UNICEF: Global HIV/AIDS Responses- Epidemic update and
health sector progress towards universal access. Geneva: WHO; 2011.
2. Federal Ministry of Health: Report on Progress Towards Implementation of the
UN Declaration of Commitment on HIV/AIDS. Addis Ababa: Federal HIV/AIDS
Prevention and Control Office; 2010.
3. Carrieri MP, Villes V, Raffi F, Protopopescu C, Preau M, Salmon D, Taieb A,
Lang JM, Verdon R, Chene G, Spire B, APROCO-COPILOTE ANRS CO-08 Study
Group: Self-reported side-effects of anti-retroviral treatment among IDUs:
a 7-year longitudinal study. Int J Drug Policy 2007, 18(Suppl 4):288–295.
4. de Pádua Menezes CA, César CC, Bonolo PF, Acurcio FA, Guimarães MDC:
High incidence of adverse reactions to initial antiretroviral therapy in
Brazil. Braz J Med Biol Res 2006, 39(4):495–505.
5. Life expectancy of individuals on combination antiretroviral therapy in
high-income countries. http://europepmc.org/articles/PMC3130543.
6. Edwards IR, Aronson JK: Adverse drug reactions: definition, diagnosis, and
management. Lancet 2000, 356:1255–1259.
7. Eluwa GI, Badru T, Akpoigbe KJ: Adverse drug reactions to antiretroviral
therapy (ARVs): incidence, type and risk factors in Nigeria. BMC Clin
Pharmacol 2012, 12:7.
8. de Pádua CA M, César CC, Bonolo PF, Acurcio FA, Guimarães MC:
Self-reported adverse reactions among patients initiating antiretroviral
therapy in Brazil. BJID 2007, 11(Suppl 1):20–26.
9. Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI:
Adverse drug reactions in adult medical inpatients in a South African
hospital serving a community with a high HIV/AIDS prevalence: prospective
observational study. Br J Clin Pharmacol 2008, 65(Suppl 3):396–406.
10. Pulagam P, Rajesh R, Vidyasagar S, Varma D: Assessment of hematological
adverse drug reactions to antiretroviral therapy in HIV positive patients
at Kasturba Hospital Manipal. BMC Infect Dis 2012, 12(Suppl 1):55.
11. Nagpal M, Tayal V, Kumar S, Gupta U: Adverse drug reactions to
antiretroviral therapy in AIDS patients at a tertiary care hospital in India:
a prospective observational study. Indian J Med Sci 2010, 64:245–252.
12. Montessori V, Press N, Harris M, Akagi L, Montaner JSG: Adverse effects of
antiretroviral therapy for HIV infection. CMAJ 2004, 170(2):229–238.
13. Granta DA, Mngadib TK, van Halsemaa LC, Luttigb MM, Fieldinga LK,
Churchyard JG: Adverse events with isoniazid preventive therapy:
experience from a large trial. AIDS 2010, 24(suppl 5):29–36.
14. Singh H, Dulhani N, Tiwari P, Singh P, Sinha T: A prospective, observational
cohort study to elicit adverse effects of antiretroviral agents in a remote
resource-restricted tribal population of Chhattisgarh. Indian J Pharmacol 2009,
41(Suppl 5):224–226.
15. Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E: Factors influencing
adherence to antiretroviral treatment in Nepal: a mixed- methods
study. PLoS ONE 2012, 7(Suppl 5):e35547. doi:10.1371/journal.pone.0035547.
16. Alexander M, Violeta N-L, Rita Chung WY, Charlotte Lam SW, Patrick Li CK,
Joseph Lau TF: Factors associated with adherence to antiretroviral
medication in HIV-infected patients. Int J STD AIDS 2002, 13:301–310.
Tadesse et al. BMC Pharmacology and Toxicology 2014, 15:32 Page 9 of 9
http://www.biomedcentral.com/2050-6511/15/3217. Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P,
Lo Caputo S, Narciso P, Pauluzzi S, Carosi G, Nappa S, Piano P, Izzo CM,
Lichtner M, Rezza G, Monforte A, Ippolito G, d'Arminio Moroni M, Wu AW,
Antinori A, AdICONA Study Group: Self-reported symptoms and medication
side effects influence adherence to highly active antiretroviral
therapy in persons with HIV infection. Jf Acquir Immune Defic Syndr 2001,
28(Suppl 5):445–449.
18. Johnson MO, Charlebois E, Morin SF, Catz SL, Goldstein RB, Remien RH,
Rotheram-Borus MJ, Mickalian JD, Kittel L, Samimy-Muzaffar F, Lightfoot MA,
Gore-Felton C, Chesney A, NIMH Healthy Living Project Team: Perceived
adverse effects of antiretroviral therapy. J Pain Symptom Manage 2005,
29(Suppl 2):193–205.
19. Malangu NG: Self-reported adverse effects as barriers to adherence to
antiretroviral therapy in HIV-infected patients in Pretoria. SA Fam Pract 2008,
50(Suppl 5):49.
20. Luma HN, Doualla M, Choukem S, Temfack E, Ashuntantang G, Joko AH,
Koulla-Shiro S: Adverse drug reactions of Highly Active Antiretroviral
Therapy (HAART) in HIV infected patients at the General Hospital,
Douala, Cameroon: a cross sectional study. Pan Afr Med J 2012, 12:87.
21. Lin MW, Sandifer R, Stein S: Effects of unemployment on mental and
physical health. Am J Public Health 1985, 75:502–506.
22. Kessler RC, Turner JB, House JS: Effects of unemployment on health in a
community survey: main, modifying and mediating effects. J Soc Issues 1988,
44(4):69–85.
23. Filho BFL, Nogueira AS SA, Machado SE, Abreu FT, de Oliveira HR, Hofer BC EL:
Factors associated with lack of antiretroviral adherence among adolescents
in a reference centre in Rio de Janeiro, Brazil. Int J STD AIDS 2008, 19:685–688.
doi:10.1258/ijsa.2008.008017.
24. Ajose O, Mookerjeeb S, Millsc EJ, Boulled A, Ford N: Treatment outcomes
of patients on second-line antiretroviral therapy in resource-limited settings:
a systematic review and meta-analysis. AIDS 2012, 26(Suppl 8):929–938.
doi:10.1186/2050-6511-15-32
Cite this article as: Tadesse et al.: Self-reported adverse drug reactions
and their influence on highly active antiretroviral therapy in HIV
infected patients: a cross sectional study. BMC Pharmacology and
Toxicology 2014 15:32.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
